Bio-Path Holdings Reports Second Quarter 2023 Financial Results

8 months ago

Conference Call to be Held Today at 8:30 A.M. ETHOUSTON, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH),…

Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023

8 months ago

Gross profit increases 178% compared to the same period last year New online store providing greater interaction with dentists and…

Gritstone bio and Genevant Sciences Announce Option and License Agreement

8 months ago

Agreement provides nonexclusive access to Genevant’s leading LNP technology for use with Gritstone bio’s self-amplifying RNA technology in wide array of…

MCI Onehealth Reports Second Quarter 2023 Financial Results

8 months ago

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, ON, Aug. 15, 2023 (GLOBE…

AIM ImmunoTech Reports Second Quarter Financial Results and Provides Clinical Pipeline Update

8 months ago

– Continued operational execution across pipeline towards multiple clinical and regulatory value-driving milestones expected in the second half of 2023…

Wound Healing Technology Company Merakris Adds Two Executives to Leadership Team

8 months ago

RESEARCH TRIANGLE PARK, N.C., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Merakris Therapeutics has added two new executives to its leadership…

TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

8 months ago

Announced pricing of approximately $5 million equity financing (approximately $5.7 million if underwriter’s overallotment option is exercised in full); expected…

Interactive Strength Inc. d/b/a FORME Reports Second Quarter 2023 Results

8 months ago

Net Loss and Earnings per Diluted Share of $13.6 million and $1.02 Adjusted EBITDA was a $5.7 million loss, a…

TFF Pharmaceuticals Prices $5 Million Public Offering of Common Stock

8 months ago

FORT WORTH, Texas, Aug. 15, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (the “Company”), a clinical-stage biopharmaceutical company…

Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update

8 months ago

ColoAlert® Revenue Increases 108% Year Over Year in the First Six Months of 2023 ColoFuture and eAArly Detect Studies on…